AAAAAA
Results:
1-14
|
Results: 14
Authors:
Lechner, O
Lauber, J
Franzke, A
Sarukhan, A
von Boehmer, H
Buer, J
Citation: O. Lechner et al., Fingerprints of anergic T cells, CURR BIOL, 11(8), 2001, pp. 587-595
Authors:
Felske, A
Pauling, BV
von Canstein, HF
Li, Y
Lauber, J
Buer, J
Wagner-Dobler, I
Citation: A. Felske et al., Detection of small sequence differences using competitive PCR: Molecular monitoring of genetically improved, mercury-reducing bacteria, BIOTECHNIQU, 30(1), 2001, pp. 142
Authors:
Hess, S
Rheinheimer, C
Tidow, F
Bartling, G
Kaps, C
Lauber, J
Buer, J
Klos, A
Citation: S. Hess et al., The reprogrammed host - Chlamydia trachomatis - Induced up-regulation of glycoprotein 130 cytokines, transcription factors, and antiapoptotic genes, ARTH RHEUM, 44(10), 2001, pp. 2392-2401
Authors:
Schrader, AJ
Probst-Kepper, M
Grosse, J
Kunter, U
Schenk, F
Franzke, A
Atzpodien, J
Buer, J
Citation: Aj. Schrader et al., Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells, MELANOMA RE, 10(4), 2000, pp. 355-362
Authors:
Schrader, AJ
Probst-Kepper, M
Grosse, J
Kunter, U
Franzke, A
Sel, S
Atzpodien, E
Buer, J
Citation: Aj. Schrader et al., Tumour microdissemination and survival in metastatic melanoma, ANTICANC R, 20(5B), 2000, pp. 3619-3624
Authors:
Walter, U
Frantzke, A
Sarukhan, A
Zober, C
von Boehmer, H
Buer, J
Lechner, O
Citation: U. Walter et al., Monitoring gene expression of TNFR family members by beta-cells during development of autoimmune diabetes, EUR J IMMUN, 30(4), 2000, pp. 1224-1232
Authors:
Oevermann, K
Buer, J
Hoffmann, R
Franzke, A
Schrader, A
Patzelt, T
Kirchner, H
Atzpodien, J
Citation: K. Oevermann et al., Capecitabine in the treatment of metastatic renal cell carcinoma, BR J CANC, 83(5), 2000, pp. 583-587
Authors:
Atzpodien, J
Janssen, J
Buer, J
Sel, S
Oevermann, K
Citation: J. Atzpodien et al., Combination therapy for treatment of advanced renal cell carcinoma, CUR CLIN ON, 4, 2000, pp. 331-341
Authors:
von Boehmer, H
Aifantis, I
Feinberg, J
Lechner, O
Saint-Ruf, C
Walter, U
Buer, J
Azogui, O
Citation: H. Von Boehmer et al., Pleiotropic changes controlled by the pre-T-cell receptor, CURR OP IM, 11(2), 1999, pp. 135-142
Authors:
Franzke, A
Peest, D
Probst-Kepper, M
Buer, J
Kirchner, GI
Brabant, G
Kirchner, H
Ganser, A
Atzpodien, J
Citation: A. Franzke et al., Autoimmunity resulting from cytokine treatment predicts long-term survivalin patients with metastatic renal cell cancer, J CL ONCOL, 17(2), 1999, pp. 529-533
Authors:
Atzpodien, J
Buer, J
Sel, S
Janssen, J
Oevermann, K
Citation: J. Atzpodien et al., Chemoimmunotherapy in the systemic treatment of advanced renal carcinoma, UROLOGE, 38(5), 1999, pp. 474-478
Authors:
Wittke, F
Hoffmann, R
Buer, J
Dallmann, I
Oevermann, K
Sel, S
Wander, T
Ganser, A
Atzpodien, J
Citation: F. Wittke et al., Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma, BR J CANC, 79(7-8), 1999, pp. 1182-1184
Authors:
Hoffmann, R
Franzke, A
Buer, J
Sel, S
Oevermann, K
Duensing, A
Probst, M
Duensing, S
Kirchner, H
Ganser, A
Atzpodien, J
Citation: R. Hoffmann et al., Prognostic impact of in vivo soluble cell adhesion molecules in metastaticrenal cell carcinoma, BR J CANC, 79(11-12), 1999, pp. 1742-1745
Authors:
Aifantis, L
Azogui, O
Feinberg, J
Saint-Ruf, C
Buer, J
von Boehmer, H
Citation: L. Aifantis et al., On the role of the pre T cell receptor in alpha beta versus gamma delta T lineage commitment, IMMUNITY, 9(5), 1998, pp. 649-655
Risultati:
1-14
|